I

Inhibrx
D

INBX

35.680
USD
0.66
(1.88%)
مغلق
حجم التداول
4,819
الربح لكل سهم
-4
العائد الربحي
-
P/E
-2
حجم السوق
516,839,821
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ أسبوع
buy
2025-09-22 04:39
INBX Chart
المزيد
الأخبار المقالات

العنوان: Inhibrx Biosciences Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.